CorMedix (CRMD) Revenue Growth (1y) (2014 - 2025)
CorMedix (CRMD) Revenue Growth (1y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 35.46% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 7.82% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 19.04% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 64.03% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | CorMedix | 4.95 Mn | -150.26 Mn | 107.31 Mn | 312.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 312.10% |
| Sep 30, 2025 | 810.22% |
| Jun 30, 2025 | 4,829.40% |
| Dec 31, 2022 | -47.33% |
| Sep 30, 2022 | -82.10% |
| Jun 30, 2022 | 159.47% |
| Mar 31, 2022 | -91.35% |
| Dec 31, 2021 | 1.23% |
| Sep 30, 2021 | -59.05% |
| Jun 30, 2021 | -50.19% |
| Mar 31, 2021 | 19.18% |
| Dec 31, 2020 | 124.85% |
| Sep 30, 2020 | 56.26% |
| Jun 30, 2020 | -53.37% |
| Mar 31, 2020 | -54.76% |
| Dec 31, 2019 | -6.58% |
| Sep 30, 2019 | -84.02% |
| Jun 30, 2019 | 367.04% |
| Mar 31, 2019 | 605.26% |
| Dec 31, 2018 | -71.33% |